These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18826913)

  • 1. Dynamics of conserved waters in human Hsp90: implications for drug design.
    Yan A; Grant GH; Richards WG
    J R Soc Interface; 2008 Dec; 5 Suppl 3(Suppl 3):S199-205. PubMed ID: 18826913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationships in purine-based inhibitor binding to HSP90 isoforms.
    Wright L; Barril X; Dymock B; Sheridan L; Surgenor A; Beswick M; Drysdale M; Collier A; Massey A; Davies N; Fink A; Fromont C; Aherne W; Boxall K; Sharp S; Workman P; Hubbard RE
    Chem Biol; 2004 Jun; 11(6):775-85. PubMed ID: 15217611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiclass comparative virtual screening to identify novel Hsp90 inhibitors: a therapeutic breast cancer drug target.
    Dunna NR; Bandaru S; Akare UR; Rajadhyax S; Gutlapalli VR; Yadav M; Nayarisseri A
    Curr Top Med Chem; 2015; 15(1):57-64. PubMed ID: 25579569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Progress in the study of heat shock protein 90 inhibitors].
    Luo HM; Sun W; Yin JY; Yang XH
    Yao Xue Xue Bao; 2010 Jul; 45(7):813-20. PubMed ID: 20931776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting wide-range oncogenic transformation via PU24FCl, a specific inhibitor of tumor Hsp90.
    Vilenchik M; Solit D; Basso A; Huezo H; Lucas B; He H; Rosen N; Spampinato C; Modrich P; Chiosis G
    Chem Biol; 2004 Jun; 11(6):787-97. PubMed ID: 15217612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of Hsp90 inhibitor dimers as potential antitumor agents.
    Muranaka K; Sano A; Ichikawa S; Matsuda A
    Bioorg Med Chem; 2008 Jun; 16(11):5862-70. PubMed ID: 18487051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and quantum chemical studies of 8-aryl-sulfanyl adenine class Hsp90 inhibitors.
    Immormino RM; Kang Y; Chiosis G; Gewirth DT
    J Med Chem; 2006 Aug; 49(16):4953-60. PubMed ID: 16884307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting conserved water molecules: design of 4-aryl-5-cyanopyrrolo[2,3-d]pyrimidine Hsp90 inhibitors using fragment-based screening and structure-based optimization.
    Davies NG; Browne H; Davis B; Drysdale MJ; Foloppe N; Geoffrey S; Gibbons B; Hart T; Hubbard R; Jensen MR; Mansell H; Massey A; Matassova N; Moore JD; Murray J; Pratt R; Ray S; Robertson A; Roughley SD; Schoepfer J; Scriven K; Simmonite H; Stokes S; Surgenor A; Webb P; Wood M; Wright L; Brough P
    Bioorg Med Chem; 2012 Nov; 20(22):6770-89. PubMed ID: 23018093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of dual agents as an activator of mutant p53 and inhibitor of Hsp90 by docking, molecular dynamic simulation and virtual screening.
    Abbasi M; Sadeghi-Aliabadi H; Hassanzadeh F; Amanlou M
    J Mol Graph Model; 2015 Sep; 61():186-95. PubMed ID: 26277488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large scale free energy calculations for blind predictions of protein-ligand binding: the D3R Grand Challenge 2015.
    Deng N; Flynn WF; Xia J; Vijayan RS; Zhang B; He P; Mentes A; Gallicchio E; Levy RM
    J Comput Aided Mol Des; 2016 Sep; 30(9):743-751. PubMed ID: 27562018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lead generation of heat shock protein 90 inhibitors by a combination of fragment-based approach, virtual screening, and structure-based drug design.
    Miura T; Fukami TA; Hasegawa K; Ono N; Suda A; Shindo H; Yoon DO; Kim SJ; Na YJ; Aoki Y; Shimma N; Tsukuda T; Shiratori Y
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5778-83. PubMed ID: 21875802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hsp90 inhibitors, part 1: definition of 3-D QSAutogrid/R models as a tool for virtual screening.
    Ballante F; Caroli A; Wickersham RB; Ragno R
    J Chem Inf Model; 2014 Mar; 54(3):956-69. PubMed ID: 24564321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural ensemble-based docking simulation and biophysical studies discovered new inhibitors of Hsp90 N-terminal domain.
    Kim HH; Hyun JS; Choi J; Choi KE; Jee JG; Park SJ
    Sci Rep; 2018 Jan; 8(1):368. PubMed ID: 29321504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Could the FDA-approved anti-HIV PR inhibitors be promising anticancer agents? An answer from enhanced docking approach and molecular dynamics analyses.
    Arodola OA; Soliman ME
    Drug Des Devel Ther; 2015; 9():6055-65. PubMed ID: 26622167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of neolamellarin a derivatives targeting heat shock protein 90.
    Jiang L; Yin R; Wang X; Dai J; Li J; Jiang T; Yu R
    Eur J Med Chem; 2017 Jul; 135():24-33. PubMed ID: 28426997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal strategies for virtual screening of induced-fit and flexible target in the 2015 D3R Grand Challenge.
    Ye Z; Baumgartner MP; Wingert BM; Camacho CJ
    J Comput Aided Mol Des; 2016 Sep; 30(9):695-706. PubMed ID: 27573981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards the In-silico Design of New HSP90 Inhibitors: Molecular Docking and 3D-QSAR CoMFA Studies of Tetrahydropyrido [4, 3-d] Pyrimidine Derivatives as HSP90 Inhibitors.
    Sepehri B; Ghavami R
    Med Chem; 2018; 14(5):439-450. PubMed ID: 29564982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular modelling and docking studies on heat shock protein 90 (Hsp90) inhibitors.
    Saxena AK; Saxena S; Chaudhaery SS
    SAR QSAR Environ Res; 2010 Jan; 21(1):1-20. PubMed ID: 20373211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of N-(5-chloro-2,4-dihydroxybenzoyl)-(R)-1,2,3,4-tetrahydroisoquinoline-3-carboxamides as novel Hsp90 inhibitors.
    Liang C; Hao H; Wu X; Li Z; Zhu J; Lu C; Shen Y
    Eur J Med Chem; 2016 Oct; 121():272-282. PubMed ID: 27266997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico identification and computational analysis of the nucleotide binding site in the C-terminal domain of Hsp90.
    Roy SS; Kapoor M
    J Mol Graph Model; 2016 Nov; 70():253-274. PubMed ID: 27771574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.